By Daniella Parra Imviva Biotech said data showed its CTA313 drug resulted in 50% of...

By Daniella Parra SkylineDx shared new findings in cutaneous squamous cell carcinoma (CSCC) research that...

By Karen Roman NanoViricides, Inc. (NYSE: NNVC) said the recent outbreak of the hantavirus on...

By Daniella Parra Glucotrack, Inc. (Nasdaq: GCTK) said it has submitted an Investigational Device Exemption...

By Karen Roman NanoViricides, Inc. (NYSE: NNVC) said the FDA granted “Orphan Drug Designation” (ODD)...

By Karen Roman Agilent Technologies, Inc. (NYSE: A) said it designated Michael Buckner as Chief...

By Daniella Parra Glucotrack, Inc. (Nasdaq: GCTK) shared a study highlighting the long-term accuracy of...

By Daniella Parra CareDx (Nasdaq: CDNA) said it signed a definitive agreement to acquire Naveris,...

By Exec Edge Editorial Staff Most patients never meet their anesthesiologist before surgery day. They...

By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said it started two new U.S. collaborations...